[S-40] Symposium 40「Nobel Prize research put into practical use one after another!　The cutting edge of ATTR amyloidosis treatment」

[S-40-3] CRISPR-based Gene Editing Therapy in Development for ATTR Amyloidosis

Liron Walsh (Intellia Therapeutics, USA)

1991：Graduated from Faculty of Medicine, Kyoto University, Kyoto, Japan
1999：Graduated from Graduate School of Medicine, Kyoto University
2000－2002：Clinical Fellow, Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA
2002－2005：Assistant Professor, Human Brain Research Center, Kyoto University Graduate School of Medicine
2005－2011：Chief of the 1st Section, Department of Functional Brain Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Kyoto, Japan
2011－2021：Department Director, Integrative Brain Imaging Center, NCNP
2019－present：Professor, Department of Integrated Neuroanatomy and Neuroimaging, Kyoto University Graduate School of Medicine